Letybo
MarketedBotulinum toxin product produced in-house; launched in India in July 2026.
A medical aesthetics company that makes botulinum toxin, hyaluronic acid fillers, skin boosters, threads and cosmetics.
Botulinum toxin product produced in-house; launched in India in July 2026.
Hyaluronic acid filler brand; in July 2026 the company launched The Chaeum Signature in Korea, made with its Multi Purified Crosslinking process that cuts crosslinker use by more than 50%.
Dermocosmetics brand whose Real Hyaluronic line is expanding distribution in the U.S. and Canada.
Head office and factory in the Geodu complex, Dongnae-myeon, Chuncheon, Gangwon-do, where botulinum toxin drug-substance processes (bacterial culture and purification) and finished-product processes run.
Launched The Chaeum Signature, a hyaluronic acid filler using Multi Purified Crosslinking to lower residual crosslinker, in Korea in four formulations.
Officially launched the botulinum toxin Letybo in India through local distributor Aakaar Medical.
With OLIVE YOUNG, placed five WELLAGE Real Hyaluronic products in OLIVE YOUNG's K-Beauty Edit display at Sephora stores in the U.S.
Individual vacancy
Observed 2026-10-25
Individual vacancy
Observed 2026-10-25
A brief based on selected official material, not an exhaustive product or vacancy list.